Searched for
DRUG PROBLEM IN INDIA
The young people we never seeRecent research underscores the importance of social interaction in mitigating adolescent substance abuse risks. Key elements, such as a se...- First terrorism, then Naxalism, now drugs: By 2029, Amit Shah sets hard deadline to wipe out India’s narcotics menace & Punjab crisisUnion home minister Amit Shah has set December 31, 2029, as the target to make India drug-free, saying the Centre will focus on tackling th...
- AAP chief Aravind Kejriwal questions HM Amit Shah over drug menace in BJP-ruled statesArvind Kejriwal criticised Amit Shah for the ongoing drug issues in BJP-ruled states like Bihar and Gujarat. Shah had expressed his sadness...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThe last few weeks have made one thing clear. Oil prices, US bond yields, corporate earnings, and the state of the world – all point the sa...
- Amit Shah hails security personnel for violence-free Bengal pollsUnion home minister Amit Shah confirmed that peace has been established in Kashmir, the Northeast, and Naxal-affected areas. He highlighted...
- HealthRail: Turning India's hospital receivables into growth capitalIn a strategic move to streamline hospital cash flow, HealthRail is offering expedited access to accrued revenues. This initiative specific...
- Protests can become instruments of political interests, fuel divisions: Mohan BhagwatAt the annual Vijayadashami event, Mohan Bhagwat shared important insights on the risks associated with regime-change protests. He suggeste...
- Don't stunt the stent, med devices sectorThree coronary stent models from Meril Life Sciences were withdrawn from the Sri Lankan market due to performance issues. The National Medi...
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
- India's internal security landscape has changed irrevocably: Union Home SecretaryUnion Home Secretary Govind Mohan on Saturday said India’s internal security challenges have changed, with Naxalism largely ended, insurgen...
- ‘For global trade’s sake, hope our US deal is inked soon’: FM Nirmala SitharamanNirmala Sitharaman expressed optimism regarding the speedy conclusion of the India-US trade agreement during her recent interaction. She hi...
- Health ministry asked to examine coronary stent safety concernsCabinet secretariat has directed the Union health ministry to investigate safety issues related to coronary stents. These concerns were rai...
- School Assembly News Headlines, October 14, 2026: Check national, international, business, sports updates and thought of the daySchool assemblies are essential in keeping students updated on crucial happenings both nationally and globally. Recently, the Supreme Court...
- Need regional resolve to deter terror: Amit ShahAddressing the first Home Ministers' Meeting of BIMSTEC countries, Amit Shah said India follows a policy of zero tolerance towards terroris...
- Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
- Anupam Rasayan eyes US, Europe pharma push after Bliss deal, one-third revenue from drugsAnupam Rasayan India Ltd anticipates significant growth in its pharmaceutical segment over the next three years. The company expects pharma...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhat is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...
- In healthcare, the patient is the least informed consumerSignificant price differences in healthcare consumables have drawn attention, prompting calls for better consumer protection. Maharashtra's...
Load More
